José Luis
Pérez Gracia
Consultor Médico
Pontificia Universidad Católica de Chile
Santiago de Chile, ChilePontificia Universidad Católica de Chile-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2019
-
Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: An updated analysis of keynote-010 trial
Annals of Oncology, Vol. 30, Núm. 2, pp. 281-289
2016
-
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial
The Lancet, Vol. 387, Núm. 10027, pp. 1540-1550